Thanks, Roger. There’s something about that that just doesn’t sit well with me. How do they know that the difference between the near relatives is not the crucial difference. After all, deadly nightshade is a close relative of tomatoes. And what does malaria have to do with it … a completely different sort of organism.
Anyway, I like the dream.
Nick
Nicholas Thompson
Emeritus Professor of Ethology and Psychology
Clark University
https://wordpress.clarku.edu/nthompson/
From: Friam <[hidden email]> On Behalf Of Roger Critchlow
Sent: Tuesday, April 28, 2020 1:21 PM
To: The Friday Morning Applied Complexity Coffee Group <[hidden email]>
Subject: Re: [FRIAM] In Race for a Coronavirus Vaccine, an Oxford Group Leaps Ahead - The New York Times
They have a leg up because they already tested a close relative of their vaccine for safety. That's the first step in clinical trials, to prove that you do no harm. So they've modified that already tested vaccine for the current pandemic and they're ready to go directly to efficacy trials.
-- rec --
On Tue, Apr 28, 2020 at 12:15 PM <[hidden email]> wrote:
Hi, all,
Can anybody explain the leg-up that Oxford group has because of their work on Malaria?
.-. .- -. -.. --- -- -..-. -.. --- - ... -..-. .- -. -.. -..-. -.. .- ... .... . ...
FRIAM Applied Complexity Group listserv
Zoom Fridays 9:30a-12p Mtn GMT-6 bit.ly/virtualfriam
unsubscribe http://redfish.com/mailman/listinfo/friam_redfish.com
archives: http://friam.471366.n2.nabble.com/
FRIAM-COMIC http://friam-comic.blogspot.com/
| Free forum by Nabble | Edit this page |